Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines
NCT05292638 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2022-11-17
Summary
A single-center, randomized, double-blind, single-injection, active-controlled, parallel-design study to evaluate the safety and efficacy of CKDB-501A in Glabellar lines.
Conditions
- Glabellar Lines
Interventions
- DRUG
-
CKDB-501A
Intramuscular injection CKDB-501A
- DRUG
-
Botox®
Intramuscular injection Botox®
Sponsors & Collaborators
-
CKD Bio Corporation
lead INDUSTRY
Principal Investigators
-
beomjoon Kim · Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-15
- Primary Completion
- 2022-06-10
- Completion
- 2022-06-10
Countries
- South Korea
Study Locations
More Related Trials
-
Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
NCT03970876 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05217355 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Moderate to Severe Glabellar Lines
NCT04249583 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
NCT06308198 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
NCT01629875 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01237977 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
NCT07013279 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248893 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT06212960 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines
NCT04622254 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
NCT02961673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BOTOX® in the Treatment of Crow's Feet Lines in China
NCT02195687 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
NCT01391312 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines
NCT05364580 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)
NCT03894748 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03736928 ·Status: COMPLETED ·Phase: PHASE2
-
Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines
NCT06151561 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
NCT04225260 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01776606 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
NCT04143815 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01940991 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Moderate to Severe Lateral Canthal Lines
NCT04249687 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines
NCT06199336 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles
NCT07072806 ·Status: COMPLETED ·Phase: PHASE4